Aug.25.2017 / 10:24 AM ET
Let our news meet your inbox.
From clot-busting drugs to bypass surgery, cardiologists have many options for treating the 700,000-plus Americans who suffer a heart attack each year. But treatment options remain limited for the 5.7 million or so Americans who suffer from heart failure, an often debilitating condition in which damage to the heart (often resulting from a heart attack) compromises its ability to pump blood.
Severe heart damage can pretty much incapacitate people, says Dr. Timothy Henry, director of cardiology at the Cedars-Sinai Medical Center in Los Angeles. You cant climb a flight of stairs, youre fatigued all the time, and youre at risk of sudden cardiac arrest.
Medication is available to treat heart failure, but its no panacea. And some heart failure patients undergo heart transplantation, but it remains an iffy proposition even 50 years after the first human heart was transplanted in 1967.
But soon, there may be another option.
A patch for the heart
Researchers are developing a new technology that would restore normal cardiac function by covering scarred areas with patches made of beating heart cells. The tiny patches would be grown in the lab from patients own cells and then surgically implanted.
The patches are now being tested in mice and pigs at Duke University, the University of Wisconsin and Stanford University. Researchers predict they could be tried in humans within five years with widespread clinical use possibly coming within a decade.
The hope is that patients will be again to live more or less normally again without having to undergo heart transplantation which has some serious downsides. Since donor hearts are in short supply, many patients experiencing heart failure die before one becomes available. And to prevent rejection of the new heart by the immune system, patients who do receive a new heart typically must take high doses of immunosuppressive drugs.
Heart transplants also require bypass machines which entails some risk and complications, says Dr. Timothy Kamp, co-director of the University of Wisconsins Stem Cell and Regenerative Medicine Center and one of the researchers leading the effort to create heart patches. Putting a patch on doesnt require any form of bypass, because the heart can continue to pump as it is.
To create heart patches, doctors first take blood cells and then use genetic engineering techniques to reprogram them into so-called pluripotent stem cells. These jack-of-all-trade cells, in turn, are used to create the various types of cells that make up heart muscle. These include cardiomonocytes, the cells responsible for muscle contraction; fibroblasts, the cells that give heart tissue its structure; and endothelial cells, the cells that line blood vessels.
These cells are then grown over a tiny scaffold that organizes and aligns them in a way that they become functional heart tissue. Since the patches would be made from the patients own blood cells, there would be no chance of rejection by the patients immune system.
Once the patch tissue matures, MRI scans of the scarred region of the patients heart would be used to create a digital template for the new patch, tailoring it to just the right size and shape. A 3D printer would then be used to fabricate the extracellular matrix, the pattern of proteins that surround heart muscle cells.
The fully formed patch would be stitched into place during open-heart surgery, with blood vessel grafts added to link the patch with the patients vascular system.
In some cases, a single patch would be enough. For patients with multiple areas of scarring, multiple patches could be used.
Inserting patches will be delicate business, in part because scarring can render heart walls thin and susceptible to rupture. Researchers anticipate that heart surgeons will look at each case individually and decide whether it makes more sense to cut out the scarred area and cover the defect with a patch or simply affix the patch over the scarred area and hope that, over time, the scars will go away.
Another challenge will be making sure the patches contract and relax in synchrony with the hearts onto which theyre grafted. We think this will happen because cells of the same type like to seek each other out and connect over time, Kamp says. We anticipate that if the patch couples with the native heart tissue, the electrical signals which pass through the heart muscle like a wave and tell it to contract, will drive the new patch to contract at the same rate.
How much would it cost to patch a damaged heart? Researchers put the price tag at about $100,000. Thats far less than the $500,000 or so it costs give a patient a heart transplant. And regardless of the cost, researchers are upbeat about the possibility of having a new way to treat heart failure.
Using these patches to repair the damaged muscle is likely to be very effective, says Henry. Were not quite there yet itll be a few years before you see the first clinical trials. But this technology may really provide a whole new avenue of hope for people with these conditions who badly need new treatment options.
FOLLOW NBC MACH ON TWITTER, FACEBOOK, AND INSTAGRAM.
Let our news meet your inbox.
- COVID-19 Stem Cell Therapies Pipeline, 2020 Report - ResearchAndMarkets.com - Business Wire - May 9th, 2020
- Role of science highlighted in pandemic fight - Chinadaily.com.cn - - May 9th, 2020
- UB investigators uncover cellular mechanism involved in Krabbe disease - UB Now: News and views for UB faculty and staff - University at Buffalo... - May 9th, 2020
- Gilbert Paterson band students to participate in worldwide documentary - Medicine Hat News - May 9th, 2020
- Heard On Sundial: Reopening Miami-Dade And The Keys, And Stem Cell Treatment For Coronavirus - WLRN - May 7th, 2020
- Researchers Convert Astrocytes to Neurons In Vivo to Treat... : Neurology Today - LWW Journals - May 7th, 2020
- Results From Pivotal Phase 2/3 Study of Emapalumab in Patients With Primary HLH Published in New Eng - PharmiWeb.com - May 7th, 2020
- BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn for The European Union - GlobeNewswire - May 7th, 2020
- Characterization and Immunomodulation of Canine Amniotic Membrane Stem | SCCAA - Dove Medical Press - May 7th, 2020
- Lineage Cell Therapeutics Reports New Data With OpRegen for the Treatment of Dry AMD With Geographic Atrophy - BioSpace - May 7th, 2020
- Navigating cancer as a young adult: 'I'm trying to figure out who I am' - Stanford Medical Center Report - May 7th, 2020
- Orgenesis leads the charge at an exciting time for cell and gene therapy - Proactive Investors USA & Canada - May 7th, 2020
- DIABETES RESEARCH INSTITUTE FOUNDATION RECEIVES $3 MILLION GIFT FROM NORTH AMERICA'S BUILDING TRADES UNIONS TO FUND CELL THERAPY FOR COVID-19 -... - May 7th, 2020
- End-use Industries of Stem Cell Assay Product Witness Unparalleled Slowdown Induced by Global Outbreak of COVID-361 - 3rd Watch News - May 7th, 2020
- FDA Approves Tabrecta, the First Targeted Drug for Patients with Non-Small Cell Lung Cancer and MET exon 14 - Curetoday.com - May 7th, 2020
- UAE stem cell therapy: Revolutionary treatment helps cure COVID-19 patients - Gulf News - May 3rd, 2020
- Institute for Stem Cell Science and Regenerative Medicine ... - April 29th, 2020
- Scientists from Universities in Russia and Ukraine Collaborate to Research on New Approaches to Treat Obesity and Diabetes - QS WOW News - April 29th, 2020
- Organoids: Exploring Liver Cancer Initiation and the Possibilities of Personalized Glioblastoma Treatment - Technology Networks - April 29th, 2020
- Cell Culture Protein Surface Coating Market Competitive Analysis and Forecast 2017-2025 - Latest Herald - April 29th, 2020
- Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19 - BioSpace - April 29th, 2020
- Stem Cell Treatment Options | National Stem Cell Clinic - April 28th, 2020
- Impact of COVID-19 on Stem Cell Assay Market In-Depth Analysis And Forecast 2020-2027 | By Top Key Players Merck & Co., Thermo Fisher Scientific,... - April 28th, 2020
- Dr Annalisa Jenkins on healthcare and biotech investments for family offices - Campden FB - April 28th, 2020
- Researcher says stem cell activation could lie at root of health effects of many natural products - NutraIngredients-usa.com - April 24th, 2020
- Researchers use cell therapy to recover damaged brain areas in mice that suffered - Mirage News - April 24th, 2020
- Scientists explore using CAR-T and other engineered immune cells to target COVID-19 - FierceBiotech - April 24th, 2020
- Lessons for medical profession during management of covid-19 pandemic: Is there a silver lining? - Elets - April 24th, 2020
- Scientists from IKBFU, Moscow and Kiev conducted research on treating obesity - Science Codex - April 24th, 2020
- Outlook on the Worldwide Amniotic Membrane Industry to 2027 - Strategic Recommendations for New Entrants - Yahoo Finance - April 24th, 2020
- Regenerative Medicine Market With Economic Growth And Five Forces Analysis By 2024 - Kentucky Journal 24 - April 21st, 2020
- Northwestern Scientists Awarded Top Honors for Achievement in Clinical Research - Northwestern University NewsCenter - April 17th, 2020
- Campus labs produce sample-preserving fluid for COVID-19 test kits - University of California - April 17th, 2020
- Leading the Movement Towards Direct Cell Conversion: An Interview With Mogrify - Technology Networks - April 17th, 2020
- What exactly are underlying conditions? And why people with them may experience more serious illness from coronavirus - Boston News, Weather, Sports |... - April 17th, 2020
- Pandemic reveals another shortcoming in preparation: Scattershot, chaotic research for treatments - Anchorage Daily News - April 17th, 2020
- Stem Cell Therapy Market to 2027 - Global Analysis and Forecasts by Type; Treatment; Application; End User, and Geography - Salamanca Press - April 15th, 2020
- UCSD scientists find possibilities for injured brain cells to be repaired - fox5sandiego.com - April 15th, 2020
- Stem cell therapies slowly gain traction as viable treatments for brain disorders - Science Magazine - April 15th, 2020
- CareDx Introduces AlloCell: Cell Therapy SurveillanceCareDx Announces Collaborations to Develop Cellular Therapy Diagnostics - BioSpace - April 15th, 2020
- NantKwest and ImmunityBio Announce Therapeutics and Vaccines for Combatting COVID-19; Clinical Trials Anticipated to Begin This Quarter - BioSpace - April 15th, 2020
- Leading Urology KOLs Host Live Webinar Entitled The Protect PNS for OAB: A Wireless Uro-Stimulation Injectable Technology on April 29 at 5pm ET -... - April 15th, 2020
- Young-onset Parkinson's may start in the womb - Health24 - April 15th, 2020
- Horizon Research Fellow job with UNIVERSITY OF LEEDS | 203439 - Times Higher Education (THE) - April 15th, 2020
- What You Need to Know About the FDA's Approval of Opdivo-Yervoy for Hepatocellular Carcinoma - Curetoday.com - April 8th, 2020
- MSC-based therapies from Mesoblast, Cynata advance to tackle COVID-19 ARDS - BioWorld Online - April 8th, 2020
- CYTOVIA Therapeutics and MACROMOLTEK to Develop Dual-Acting Natural Killer Immunotherapy Against SARS CoV2 (COVID-19) | DNA RNA and Cells | News... - April 8th, 2020
- AlloVir Appoints Ugo Capolino Perlingieri Head of Europe and Middle East Operations - Yahoo Finance - April 8th, 2020
- What does the public know about COVID-19? - University of Miami - April 8th, 2020
- India Based Stem Cell Research Firm To Test Its Stem Cell Product For Acute Respiratory Disease Syndrome (ARDS) COVID-19 - IndianWeb2.com - April 8th, 2020
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2020 Size, Share and Growth Analysis Research Report by 2025. Top Companies are... - April 8th, 2020
- Fate Inks $100M Deal With Janssen for Stem Cell-Derived Cancer Therapies - Xconomy - April 6th, 2020
- Mesoblast's remestemcel-L receives FDA IND clearance for treating COVID-19 patients with acute respiratory distress - Small Caps - April 6th, 2020
- Symtomax: the science behind producing high quality medical cannabis - Health Europa - April 6th, 2020
- Stem Cell Therapy for Colon Cancer - The Ritz Herald - April 6th, 2020
- Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027) - Publicist360 - April 6th, 2020
- Dr. Bart Rademaker Offers Free Classes On Stem Cell Therapy And The Coronavirus - PR Web - April 6th, 2020
- BioIVT Opens New Blood Donor Center to Support Boston-area Research into COVID-19 Therapies, Vaccines and Diagnostics - PRNewswire - April 6th, 2020
- Stem Cell Assay Industry - Market Demand | Recent Trends and Developments Analys - News by aeresearch - April 6th, 2020
- GoBroad Healthcare Group Commences Construction of its Research Hospital in Beijing - PRNewswire - March 30th, 2020
- Reviewing CRYO-CELL International (OTCMKTS:CCEL) and Harsco (OTCMKTS:HSC) - Redmond Register - March 29th, 2020
- Study offers potential breakthrough in the war on antibiotic-resistant superbugs - Yahoo Finance - March 26th, 2020
- European Medicines Agency Grants Orphan Drug Designation to AlloVirs Viralym-M, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Cell Therapy -... - March 26th, 2020
- Vitro Biopharma First Quarter ended January 31, 2020 Financial Results of Operations - Benzinga - March 26th, 2020
- Over 65s and vulnerable islanders in Jersey to be put in lockdown - ITV News - March 26th, 2020
- Bone Therapeutics appoints Stefanos Theoharis as Chief Business Officer - OrthoSpineNews - March 26th, 2020
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market : Worldwide Business Analysis and Prediction 2020-2025 || Top Players AVRA Medical... - March 26th, 2020
- The Global Cell Culture Market is expected to grow from USD 14,923.23 Million in 2018 to USD 35,236.23 Million by the end of 2025 at a Compound Annual... - March 25th, 2020
- The Global Cell Isolation/Cell Separation Market is expected to grow from USD 5,721.23 Million in 2018 to USD 15,089.25 Million by the end of 2025 at... - March 25th, 2020
- How Crucial is the Cellular Communications Between the Detached Cancerous Cells and Fibroblast for Growing Metastasis - Spark Health MD - March 25th, 2020
- Partner Therapeutics Announces Initiation of Clinical Trial to Evaluate Leukine in Patients with COVID-19 Associated Respiratory Illness - P&T... - March 25th, 2020
- Sangamo Therapeutics: Market Cap Is At A Bargain Relative To Its Cash Position - Seeking Alpha - March 25th, 2020
- AlloVir expands its research collaboration with Baylor College of Medicine | - University Business - March 24th, 2020
- Mustang Bio Reports Full-Year 2019 Financial Results and Recent Corporate Highlights - Yahoo Finance - March 22nd, 2020
- How Skin Cells Prepare To Heal Wounds - Technology Networks - March 22nd, 2020
- Physicians Education Resource to Host Live CME Webcast on COVID-19 and Cancer Care - Yahoo Finance - March 22nd, 2020
- A timely Q&A with Bears tight end and 'resident scientist' Ben Braunecker - The Athletic - March 22nd, 2020
- Immunotherapy using 'young cells' offers promising option against cancer - Washington University School of Medicine in St. Louis - March 21st, 2020
- Stem Cell And Regenerative Therapy Market Research Insights Global Industry Outlook Shared in Detailed Report, Forecast size 2024 - Daily Science - March 21st, 2020
- The personal and economic burden of traumatic brain injury - Eagle & Times - March 21st, 2020